BioSpace News Archive

Biotech Bay

Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer Patients

Accuray Incorporated (NASDAQ: ARAY) announced today that a study published in Frontiers in Oncology found early-stage breast cancer patients could experience significant improvements in survival if treated with accelerated partial breast irradiation (APBI) delivered using the Accuray CyberKnife

October 25, 2021
·
7 min read
Business

BridgeBio Pharma, Inc. Appoints Pioneering National Leader in Genomics and Workforce Diversity Hannah Valantine to its Board of Directors

BridgeBio Pharma, Inc. today announced that it has added a new independent director to its board: Hannah Valantine , M.D.

October 25, 2021
·
3 min read
Business

Xeris Pharmaceuticals Enters Collaboration Agreement With Merck

Xeris Biopharma Holdings, Inc. today announced a collaboration agreement with Merck, with an option to license Xeris’ suspension-based formulation technology, XeriJect™

October 25, 2021
·
5 min read
Genetown

More than 90% of Surveyed IBS-C Patients Who Had an ER Visit or Hospitalization in the Past Year Identified Abdominal Pain as a Symptom That Led to the Visit, According to Data Announced by Ironwood Pharmaceuticals at ACG 2021

Ironwood Pharmaceuticals, Inc. will present new findings at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting and Postgraduate Course from a survey highlighting prevalence and impact of abdominal symptoms in adult patients with irritable bowel syndrome with constipation (IBS-C).

October 25, 2021
·
11 min read
Drug Development

Titan Medical Announces Completion of Pre-Clinical GLP Studies

Titan Medical Inc. announced today that it has completed its scheduled pre-clinical studies with its Enos™ robotic single access surgical system, performed in accordance with FDA’s good laboratory practice (GLP) regulations.

October 25, 2021
·
5 min read
Pharm Country

Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ SARS-CoV-2 Mutation Panel

Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea ™ SARS-CoV-2 Mutation Panel

October 25, 2021
·
8 min read
Business

Aptinyx to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021

Aptinyx Inc. today announced that the company will host a conference call and live webcast on Tuesday, November 9, 2021 at 5:00 p.m. ET to report third quarter 2021 financial results and discuss recent business highlights.

October 25, 2021
·
1 min read
Drug Development

Innovation Pharmaceuticals’ COVID-19 Clinical Trial Topline Results Anticipated to Be Reported the Week of November 8th

Innovation Pharmaceuticals today announced the Company anticipates reporting topline results the week of November 8th from its Phase 2 clinical trial of Brilacidin for treatment of moderate-to-severe COVID-19 in hospitalized patients

October 25, 2021
·
4 min read
Genetown

Arch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) FallAC5® Advanced Wound System Selected for Innovation Spotlight

Arch Therapeutics, Inc. today announced that it will be presenting at the 2021 Symposium on Advanced Wound Care (SAWC) Fall.

October 25, 2021
·
4 min read
European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders

Small Pharma Inc. today announced that it has received European patent grant number EP 3 463 323 as acceptance for its European patent application No. 17 728640.8.

October 25, 2021
·
5 min read